Journal article
Lipid-lowering therapies for cardiovascular disease prevention and management in primary care: PEER umbrella systematic review of systematic reviews.
Abstract
OBJECTIVE: To assess the benefits and harms of lipid-lowering therapies used to prevent or manage cardiovascular disease including bile acid sequestrants (BAS), ezetimibe, fibrates, niacin, omega-3 supplements, proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitors, and statins.
DATA SOURCES: MEDLINE, the Cochrane Database of Systematic Reviews, and a grey literature search.
Authors
Dugré N; Lindblad AJ; Perry D; Allan GM; Braschi É; Falk J; Froentjes L; Garrison SR; Kirkwood JEM; Korownyk CS
Journal
Canadian Family Physician, Vol. 69, No. 10, pp. 701–711
Publisher
The College of Family Physicians of Canada
Publication Date
10 2023
DOI
10.46747/cfp.6910701
ISSN
0008-350X